Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
Business
From
CNBC.com News
Pfizer to price Covid drug Paxlovid at $1,390 per course
October 18, 2023
Tags
Business News
Pharmaceuticals
Pfizer Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
October 16, 2023
Tags
Procter & Gamble Co
Technology
Investment strategy
From
CNBC.com News
Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump
October 13, 2023
Tags
Health care industry
Business
Pfizer Inc
From
CNBC.com News
New RSV protections for infants hit cost, insurance hurdles in U.S. rollout
October 13, 2023
Tags
Health & Science
Health insurance
Sanofi SA
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Business News
Consumer Finance
Eli Lilly and Co
From
CNBC.com News
Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall
October 07, 2023
Tags
Breaking news
Biotech and Pharmaceuticals
Novavax Inc
From
CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
October 04, 2023
Tags
Biotechnology
US: News
Health & Science
From
CNBC.com News
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.
October 03, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
Pfizer Inc
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Biotechnology
US: News
Health & Science
From
CNBC.com News
Mum's the bad word: Most big Menendez donors won't say if they will keep backing New Jersey senator
September 26, 2023
Tickers
LAW
LAWS
Tags
Campaign Finance
Law
Congress
From
CNBC.com News
Pfizer restarts production at tornado-hit North Carolina plant, but drug supply will still be affected
September 25, 2023
Tags
Breaking news
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
Tags
Social issues
Companies
Health care industry
From
CNBC.com News
Providers struggle to get latest Covid shots into arms amid early supply issues
September 21, 2023
Tags
Retail
Retail industry
Pfizer Inc
From
CNBC.com News
You can get more free Covid-19 tests mailed to your door, starting Monday—here's how
September 21, 2023
Tags
Make It / Spend
Personal finance
Make It
From
CNBC.com News
Fall Covid shot rollout gets off to a bumpy start as some patients see insurance delays
September 20, 2023
Tags
Breaking news
Elevance Health Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Uninsured Americans can still get free Covid boosters — here's how to find them
September 19, 2023
Tags
Novavax Inc
Business
Pfizer Inc
From
CNBC.com News
Cramer's Lightning Round: Tilray is 'too dangerous'
September 18, 2023
Tags
S&P 500
Stock Picks
Business News
From
CNBC.com News
Stocks making the biggest moves midday: Marathon Petroleum, Tesla, Moderna and more
September 18, 2023
Tags
Marathon Petroleum Corp
Tesla Inc
Tenable Holdings Inc
From
CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
September 15, 2023
Tags
Kroger Co
Breaking news
Biotech and Pharmaceuticals
From
CNBC.com News
New Covid vaccines could reach Americans as soon as Thursday – here's what you need to know
September 13, 2023
Tags
Biotechnology
US: News
CVS Health Corp
From
CNBC.com News
Stocks making the biggest moves premarket: Moderna, American, Spirit Air, Ford and more
September 13, 2023
Tags
Moderna Inc
Economy
Finance
From
CNBC.com News
CDC advisors recommend updated Covid vaccines for all Americans ages 6 months and up
September 12, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
Pfizer Inc
From
CNBC.com News
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
September 11, 2023
Tags
Pfizer Inc
Business
Novavax Inc
From
CNBC.com News
Covid vaccine rollout begins early in the UK with new variant under watch
September 11, 2023
Tags
Coronavirus
Health & Science
Europe News
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Technology
From
CNBC.com News
Covid hospitalizations spike with new variant as school returns, U.S. readies vaccines
September 06, 2023
Tags
Moderna Inc
Health care industry
Business News
From
CNBC.com News
Moderna says updated Covid vaccine was effective against highly mutated BA.2.86 variant in trial
September 06, 2023
Tags
Pharmaceuticals
COVID/19
Health care industry
From
CNBC.com News
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
September 05, 2023
Tags
Pfizer Inc
Business
Biotech and Pharmaceuticals
From
CNBC.com News
When to wear masks as Covid cases rise, new variants emerge in the U.S.
September 01, 2023
Tags
Health & Science
Biotechnology
Coronavirus
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.